Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its impact on glucose metabolism and energy balance. Research focuses on its potential to influence insulin secretion, appetite regulation, and lipid metabolism. It is a next-generation peptide under investigation for its multi-pathway approach to metabolic health.
